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ABSTRACT
Objective: Literature on the treatment of dissociative disorders (DDs) suggests that these
individuals require long-term and specialized treatment to achieve stabilization and function-
ality. There is considerable empirical support for specialized phasic, dissociation-focused
treatment in reducing a myriad of psychological symptoms and self-harm in this population.
However, until recently, there has been a paucity of longitudinal treatment research on DD
patients.
Method: In the present six-year follow-up study, 61 therapists who participated in the initial
phase of the Treatment of Patients with Dissociative Disorders (TOP DD) study answered
questionnaires about their study patient’s stressors, quality of life, global functioning, victi-
mization, and safety. These results provided a view of patients’ progress six years since the
beginning of the TOP DD study.
Results: Longitudinal analyses demonstrated patients had significantly fewer stressors
(Χ2(6) = 18.76, p < .01, canonical r = .48, N = 76), instances of sexual revictimization
(X2(1) = 107.05, p < .001) and psychiatric hospitalizations (t(54) = 2.57, p < .05, Cohen’s
d = .43), as well as higher global functioning (Χ2(2) = 59.27, p < .001, canonical r = .65, N = 111).
Conclusions: These findings continue to support the initial results of the TOP DD study that,
despite marked initial difficulties and functional impairment, DD patients benefit from spe-
cialized treatment.
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Patients with dissociative disorders (DDs) suffer from
severe psychiatric symptoms, complex emotional,
social, and physical health difficulties, and high levels
of functional impairment related to chronic, severe
childhood trauma (Foote, Smolin, Kaplan, Legatt, &
Lipschitz, 2006; Johnson, Cohen, Kasen, & Brook,
2006; Putnam, 1997; Sar, AkyüZ, & Doğan, 2007).
The severity and chronicity of patients’ impairment
underscores the importance of studying the burden of
disease and effective DD treatments. Reviews and
meta-analyses have found that trauma-focused treat-
ment can be particularly beneficial for adult survivors
of childhood trauma, including DD patients (Brand,
Classen, McNary, & Zaveri, 2009; Sachsse, Vogel, &
Leichsenring, 2006). Inpatient treatment studies have
found that specialized treatment programmes reduce
posttraumatic, dissociative, interpersonal, and general
psychiatric problems among dissociative patients (Ali
& Smartt, 2009; Jepsen, Bad, Langeland, Sexton, &
Heir, 2014; Jepsen, Svagaard, Thelle, McCullough, &
Martinsen, 2009; Lampe, Hofmann, Gast,
Reddemann, & Schüßler, 2014; Rosenkranz &
Muller, 2011; Steil, Dyer, Priebe, Kleindienst, &
Bohus, 2011). Outpatient DD treatment is also asso-
ciated with enduring gains over time, including
decreased dissociative, depressive and posttraumatic
symptoms, self-destructiveness, and symptoms of
comorbid disorders, as well as increased adaptive
functioning (see Brand et al., 2009). Longitudinal
studies have been conducted with DD patients, with
durations of 1–10 years (Coons & Bowman, 2001;
Coons & Millstein, 1986; Ellason & Ross, 1997;
Jepsen et al., 2014, 2009; Kluft, 1984/1985; Lampe
et al., 2014). These studies found that patients who
remain in treatment generally show improvement in
social, psychological, and occupational functioning.
The prospective, longitudinal Treatment of Patients
with Dissociative Disorders (TOP DD) study is the
largest treatment outcome study conducted with DD
patients. TOP DD followed a large, international nat-
uralistic sample of DD patients treated by outpatient
community therapists. Results were consistent with
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previous studies in demonstrating the beneficial out-
comes of DD treatment. (For a summary of study
findings, see Supplemental data Table 1). Over
30 months, therapists reported decreases in patients’
dissociative, depressive, and posttraumatic symptoms;
decreased incidence of self-harm; suicide attempts,
drug use, and hospitalization; and increases in produc-
tive and social activities (Brand et al., 2013). In the
current study, TOP DD therapists report on patients’
safety, quality of life, global functioning, interpersonal
victimization, and stressors six years after having
enrolled in the study.
1. Methods
1.1. Participants
Participants at the six-year follow-up (T5) included
61 clinicians enrolled in the original TOP DD study;
details on recruitment, eligibility, and methodology
are available (Brand et al., 2013). Any therapist who
provided baseline (T1) data was contacted by email in
September 2013, approximately six years from the
time recruitment for the TOP DD study began, and
was invited to complete a brief, web-based survey.
TOP DD patients were not contacted to participate
due to minimal contact information and concern that
some patients no longer in treatment might experi-
ence distress about reporting on their current status.
This study received IRB approval from Towson
University and Sheppard Pratt Health System.
The TOP DD study initially collected data at four
time points (T1–T4) over 30 months. Sample sizes for
clinicians at each time point were as follows:
T1 N = 295; T2 N = 189 (64% retention); T3 N = 174
(59% retention); T4 N = 135 (46% retention). At T1,
clinicians in the current study reported that they had
worked with their patients for an average of 6.5 years
(SD = 4.5, range = 2–21 years).
1.2. Procedure
After providing informed consent, therapists indi-
cated whether their TOP DD patients were still in
treatment with them. A total of 102 therapists (35.4%
of therapist T1 sample) responded to the T5 survey.
Sixty-eight (66.67%) had completed surveys at all four
previous data points. Of these, 63 had TOP DD
patients still in treatment. Therapists who were no
longer seeing their patients reported on the reason(s)
patients were no longer in treatment and provided
study feedback. They were not invited to answer
subsequent questions. Therapists who were continu-
ing to see their patients answered questions about
patients’ current level of functioning and were
required to provide their patients’ treatment stage to
be included in study analyses. Of these patients, 4.9%
were in stage 1 (N = 3), 23% were in stage 2 (N = 14),
18% were in stage 3 (N = 11), 24.6% were in stage 4
(N = 15), and 29.5% were in stage 5 (N = 18). Two
therapists did not list their patients’ treatment stage,
yielding a final T5 sample of N = 61 (21% retention)
(see Table 1).
1.3. Measures
1.3.1. Patient treatment stage
Clinicians reported patients’ therapeutic stage, fol-
lowing expert guidelines on stage-oriented treatment
of complex trauma and dissociation (International
Society for the Study of Trauma and Dissociation
[ISSTD], 2011). Stages included 1 (i.e. stabilization
and establishing safety), 3 (i.e. processing trauma
memories) and 5 (i.e. integration and reconnection
within self and with others). Patient stage was dichot-
omized into early stage (stages 1–2) and late stage
(stages 3–5) and was controlled in analyses as a
potential confounding variable.
1.3.2. Patient stressors
At T2 through T5, clinicians reported the degree to
which stressors negatively impacted the patient’s func-
tioning and treatment over the previous six months
using a Likert scale (0 = non-applicable, 3 = somewhat,
5 = highly negative impact). Stressors were revictimi-
zation-related (sexual revictimization, physical and
emotionally abusive relationships), family-related
(family of origin, marriage, and children), therapy-
oriented (mistrust of therapist and treatment team),
resistance-related (therapeutic resistance among self-
states1 and fear of change), and resource-related
(work, money, health, and housing). In order to
increase power, stressors were merged into six compo-
site stressor scores, for each five types of stressors as
well as a total stressor score.
1.3.3. Quality of life
At T1 through T5, clinicians reported the quality of
patients’ romantic relationships, friendships, and
Table 1. Summary of therapist participants.
Therapists still treating
TOP DD Patients
Therapists with TOP DD Patients who
Terminated from Treatment
Therapists with Patients in Early Stage
of Treatment (Stages 1–2)
Therapists with Patients in




N 63 39 17 44 102
% 61.7% 38.2% 16.67% 43.13%
a Two therapists’ data excluded from analyses because stage of treatment was not included. Sample included in analyses (N = 61)
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employment status using a Likert scale (1 = lower/
poor/unstable to 5 = higher/stable). In order to
increase power, these variables were merged into a
composite quality of life (QOL) variable.
1.3.4. Global assessment of functioning
At T1 through T5, clinicians rated patients’ global func-
tioning (GAF; American Psychiatric Association, 2000)
using a Likert scale (1 = 1–10 on GAF, 2 = 11–20,
3 = 21–30, etc.), with higher scores indicating greater
psychosocial functioning, safety, and stability of
symptoms.
1.3.5. Safety
At T1–T5, clinicians reported on patients’ number of
admissions to inpatient hospitals, as well as number
of days hospitalized, within the previous six months.
Clinicians reported patients’ number of suicide
attempts and self-injurious behaviours using a scale
from 1–4 (1 = none, 2 = one, 3 = two to three,
4 = four or more) and 0–4 (0 = none, 2 = occasionally,
3 = frequently, 4 = daily or almost daily), respectively.
Due to the low frequencies, these variables were
dichotomized to three variables: (1) presence or
absence of a recent inpatient hospitalization, (2) pre-
sence or absence of a recent suicide attempt, and (3)
presence or absence of recent self-harm.
1.3.6. Intimate partner violence and sexual
revictimization
At T2–T5, clinicians reported if their patients had
experienced sexual revictimization, physical intimate
partner violence (IPV), and emotional IPV within the
previous six months, either as a victim only, perpe-
trator only, or victim–perpetrator. Each victimization
variable was dichotomized to indicate its presence or
absence. These variables grouped those who were
victims, perpetrators, and victim–perpetrators.
1.4. Analyses
Some longitudinal variables were not measured at T1,
and/or some T1 variables measured longer time per-
iods (i.e. adult lifetime) than six-month time frames
(as was measured at T5); thus, comparisons between
T2 and T5 were used in longitudinal analyses. We
used discriminant analyses (DFA) to evaluate
whether composite patient stressor scores could clas-
sify study data point, which determines whether
stressor scores significantly changed from the six
months follow-up (T2) to the six years follow-up
(T5). We used DFA to assess if QOL combined with
GAF scores could classify study data point.
DFA combines multiple continuous variables into
a linear composite predictor used to classify cases
into dichotomous categories (i.e. T5 vs. T2) and
offers follow-up univariate ANOVAs to see how indi-
vidual predictors contributed to the model. Sample
sizes for the DFA models include any participants
who provide predictor data (i.e. those who provided
only T2 data, only T5 data, or both), yielding varied
sample sizes for the DFA models. We used a multi-
variable analysis of covariance (MANCOVA) to fol-
low-up on the DFA models while controlling for
patients’ treatment stage.
We used chi-squared tests to assess the association
between study time point (T2 vs. T5) and patient
victimization (sexual revictimization, physical IPV,
emotional IPV). As chi-square requires two dichoto-
mous variables (i.e. victim status and study time
point), only T2 and T5 data were compared.
Lastly, we used paired samples t-tests and
Wilcoxon-signed rank tests to assess differences in
patient inpatient hospitalization and self-harm within
the previous six months, as well as suicide attempts
within the last year, at each time point (T1–T5); t-test
and Wilcoxon-signed rank test analyses allowed for
multiple pairwise comparisons between each time
point. Given that patient hospitalization and suicide
data did not meet assumptions of normality, both




Table 2 includes descriptive data at T2 and T5.
Thirty-nine (38.2%) of therapists’ patients were no
longer in treatment. The most common reason for
termination was objective, external factors (e.g. relo-
cation, financial constraints, medical illness; 38.5%)
followed by subjective, psychological factors (e.g. the
Table 2. Descriptive statistics for patient stressors, global assessment of functioning, and quality of life scores.
Time 2 Time 5
Variable N M (SD) Median Skew Range N M (SD) Median Skew Range
Victimization Stressors 26 2.31 (3.47) 1.50 2.67 0–15 50 1.02 (1.97) .00 3.05 0–11
Family Stressors 26 6.04 (3.64) 6 .10 0–14 50 4.10 (3.01) 3 .61 0–11
Therapy Stressors 26 2.31 (2.48) 2 1.14 0–9 50 1.36 (1.72) 1 1.33 0–6
Resistance Stressors 26 5.97 (2.44) 6.50 −.52 0–10 50 4.08 (2.66) 4 .19 0–10
Resource Stressors 26 9.23 (3.27) 10 −.11 4–15 50 7.92 (4.35) 8 −.06 0–16
Total Stressors 26 23.54 (6.66) 23 −.24 10–37 50 17.16 (9.38) 17 .28 0–38
Global Assessment of Functioning* 51 8.06 (2.82) 8 .08 3–15 60 8.38 (3.18) 8 .26 3–15
Quality of Life 51 3.86 (1.69) 4 .15 2–7 60 6.13 (1.24) 6 .01 4–9
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patient ended treatment prematurely or felt treat-
ment was not helping; 23.1%); successful resolution
of treatment without full integration of self-states
(12.8%); successful resolution of treatment with full
integration (12.8%); death due to medical problems
(5.1%); and death due to medical problems likely
exacerbated by poor self-care (2.6%).
2.2. Patient safety over time
2.2.1. Patient hospitalizations
One patient (1.6%) was admitted for an inpatient hos-
pitalization that lasted for 28 days. Paired samples
t-tests compared patient hospital admissions at each
time point in the study (T1–T5). There were signifi-
cantly fewer hospitalizations at T5 (M = .02, SD = .14)
compared to T1 (M = .13, SD = .34), t(54) = 2.57,
p < .05, Cohen’s d = .43. This significant finding repli-
cated through bootstrapping. Non-parametric tests via
Wilcoxon-signed rank test also demonstrated signifi-
cant differences in patient hospitalization at T1 as com-
pared to T5, Z = −2.45, p < .05.
2.2.2. Patient suicide attempts
One therapist reported that his/her patient had made
a suicide attempt over the previous six months
(3.3%). Paired samples t-tests found no significant
differences in number of suicide attempts over time.
Non-parametric tests via Wilcoxon-signed rank test
did not demonstrate any significant differences in
number of suicide attempts between T1–T5.
2.2.3. Patient self-harm incidents
Twenty-three therapists (43%) indicated that their
patients had not engaged in self-harm over the pre-
vious six months. Twelve (20%) reported that self-
harm occurred ‘very rarely,’ two (3.3%) reported it
occurred ‘occasionally’ (i.e. approximately once per
month), and three (5%) reported self-harm occurred
‘frequently’ (i.e. several times per month). No thera-
pists reported that their patients were engaging in
daily self-injurious behaviour. No significant differ-
ences in self-harm incidents over time were found.
2.3. Patient victimization
One therapist reported that his/her patient had experi-
enced sexual revictimization (1.6%) and another thera-
pist (1.6%) reported that his/her patient was a victim of
physical IPV within the previous six months. Nine
therapists (14.8%) indicated that they were unclear as
to whether their patients were involved in emotionally
abusive relationships. Eight reported that their patients
were victims of emotional abuse (13.1%), and one
therapist reported that his/her patient was both a vic-
tim and a perpetrator of emotional abuse (1.6%).
2.3.1. Patient victimization over time
Chi-squared tests found a significant association
between sexual revictimization and study time
point, X2(1) = 107.05, p < .001. The odds of experi-
encing recent sexual revictimization were 60 times
higher at T2 then at T5 [95% CI: 8.59–419.02]. No
associations were found between time points and
physical or emotional IPV.
2.4. Patient quality of life and global assessment
of functioning
Therapists reported considerable patient difficulties in
romantic relationships. They described 28 patients
(46%) as having ‘very poor, unstable, or absent’ roman-
tic relationships. However, they rated 18 patients’ rela-
tionships (29.5%) at a 4 or 5, with 5 representing ‘loving
and stable’ relationships. Friendships were more stable,
with 28 (45.9%) rated as ‘loving and stable.’Most experi-
enced interference with occupational functioning. Only
11 patients were described as ‘working to full potential’
(18%) and 23 patients (37.7%) were unable to keep a job
or were receiving disability. No therapists rated their
patients’GAFbelow a 3 (on a scale from 1–10), with 3 or
lower representing an inability to function in almost all
areas and possibility presenting harm to themselves
and/or others. The majority of patients were reported
as having a GAF of 6 (moderate symptoms and/or
moderate functional impairment; N = 21; 35%).
2.4.1. Quality of life and global functioning over
time
The discriminant model using QOL composite scores
and GAF scores to classify patients’ time point in the
study (T2 vs. T5) was significant,Χ2(2) = 59.27, p < .001,
canonical r = .65, N = 111. The model accounted for
65% of the variance in predicting patients’ study time
point and correctly classified 81% of cases. Follow-up
univariate ANOVAs indicated only GAF scores as a
significant predictor in the model and that GAF scores
were significantly higher at T5 vs. T2 (Table 3).
Additionally, bootstrapping demonstrated that GAF
scores were a robust predictor in the model.
2.4.2. Controlling for patient treatment stage
The MANCOVA model assessing differences in
QOL scores and GAF scores at different time points
(T2 vs. T5) controlling for treatment stage was sig-
nificant, F(2, 106) = 43.99, p < .001, ᶯ2 = .45,
N = 110. Follow-up univariate ANOVAs indicated
that GAF scores were significantly higher at T5 than
T2, F(1) = 77.85, p < .001, ᶯ2 = .42 (Table 3).
2.5. Patient stressors
Revictimization stress for sexual assault and physically
abusive relationships was absent among nearly all
4 A. C. MYRICK ET AL.
patients (98.1%), consistent with the low reporting of
victimization. Two therapists (3.8%) reported that
emotional abuse had a highly negative impact on
patients. In resource-related stressors, finance- and
health-related stressors caused a moderate level of
stress (i.e. score of 3) for 25 and 40% of patients,
respectively, while housing and work/school/volun-
teering caused less reported stress (66.67 and 48.3%
‘not at all’, respectively). Over half of therapists
reported that stressors from marriages and children
(i.e. family-related stressors) were absent (52.5 and
54.2%, respectively). Families of origin caused mod-
erate stress for 32.2% of patients.
2.5.1. Patient stressors over time
The discriminant model using the six composite
patient stressor scores to classify patients’ time point
in the study (T2 vs. T5) was significant, Χ2(6) = 18.76,
p < .01, canonical r = .48,N = 76. The model accounted
for 48% of the variance in predicting time point, cor-
rectly classifying 78% of cases. Univariate ANOVAs
indicated that revictimization, family, and resistance-
related stressor scores, as well as the total stressor score,
were significant predictors in the model, and each of
these stressors was significantly lower at T5 (Table 3).
Bootstrapping indicated that family and resistance-
related stressors were robust predictors.
2.5.2. Controlling for treatment stage
The MANCOVA model assessing differences in
patient stressors at T2 vs. T5, controlling for treat-
ment stage, was significant, F(6,68) = 3.55, p < .01,
ᶯ2 = .24, N = 76. Follow-up univariate ANOVAs
indicated that stressor scores related to victimization,
family, resistance, and the total stressors were signifi-
cantly lower at T5 (Table 3).
3. Discussion
The present study examines patients’ functioning six
years after enrolment in the TOP DD study. At T5 as
compared to T2, GAF was significantly higher and
stressors, particularly related to family relationships
and conflict among self-states, were significantly
lower, even when controlling for treatment stage.
There were also significantly fewer hospitalizations
at the follow-up time point than at the beginning of
the study. These findings indicate that patients con-
tinued to demonstrate improved functioning and had
less need for intensive and costly intervention in the
form of hospitalization. No outcome assessed in this
study worsened over time.
The decreased need for hospitalization is especially
notable; there is an immense economic cost asso-
ciated with trauma and for patients with DD in
particular (Brand, Lanius, Vermetten, Loewenstein,
& Spiegel, 2012; Ferry et al., 2015; Myrick,
Webermann, Putnam, & Brand, in press). Our results
support the view that the phasic trauma treatment
model for DD leads to reduction in the burden of
disease for patients. Further, these results are consis-
tent with prior studies that this treatment model is
associated with substantial cost savings, largely due to
reduced need for treatment at more intensive, costly
levels of care (Brand, Loewenstein, & Spiegel, 2014).
Preliminary analyses using TOP DD data show that
both hospitalization and outpatient psychotherapy
costs decreased significantly over time (Webermann,
Brown, Brand, Loewenstein, & Putnam, 2013).
Suicide attempts and parasuicidal behaviour were
not significantly different six years into treatment
among this subset of the TOP DD sample, although
both showed significant reduction in the larger TOP
DD sample (Brand et al., 2013). In this subsample,
suicide attempts were low from the beginning of the
study (T1), which suggests that almost all of these
patients were successfully maintaining safety, yet such
low rates of suicide mean that this outcome is unlikely
to improve due to a floor effect. Similarly, less than 10%
of patients in the sample were engaging in self-harm
once a month or more, and none were engaging in daily
self-harm; differences would be difficult to detect. In
contrast, in the overall TOP DD sample, at T1, self-
harmwas more common (19% engaged in self-harm on
average once per month or more and 16% made a
suicide attempt within the previous year), which is
likely why earlier analyses with the larger TOP DD
sample found improvements in both outcomes. It is
possible that this subsample has better impulse control
and/or is able to develop and maintain a better alliance
Table 3. Univariate ANOVAs of patient stressor scores, global functioning, and quality of life and time point in study.
Discriminant Analysis* MANCOVA (controlling for treatment stage)*
Variable N F (df) Canonical Coefficient F (df) Mean Square
Victimization Stressors 76 4.26 (1, 74)* .81 4.23 (1, 73)* 28.48
Family Stressors 76 6.15 (1, 74)*^ 1.09 6.13 (1, 73)* 63.63
Therapy Stressors 76 3.80 (1, 74) .75 3.88 (1, 73) 15.06
Resistance Stressors 76 9.02 (1, 74)*^ 1.09 9.40 (1, 73)* 59.66
Resource Stressors 76 1.82 (1, 74) .20 1.95 (1, 73) 28.12
Total Stressors 76 9.51 (1, 74)* −1.51 10.10 (1, 73)* 684.54
Global Assessment of Functioning 110 66.50 (1, 109)* −.46 77.85 (1, 107)* 147.99
Quality of Life 110 .32 (1, 109)* 1.13 .56 (1, 107) 4.97
* p < .05
^Replicated through bootstrapping
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than the overall sample, although those who partici-
pated in T5 did not have different levels of mistrust of
their therapists or treatment teams at T2 than those the
current subsample.
Despite patients’ GAF improving over time, many
continued to be negatively affected by daily stressors and
showed serious difficulty managing healthy relation-
ships, in line with Lampe et al.’s (2014) findings.
Nevertheless, IPV was low and sexual revictimization
declined. Similarly, family-related stressors decreased
over six years in treatment, as did internal conflict
between self-states. Interpersonal difficulties are sub-
stantial stressors for DD patients (Brand et al., 2009;
Brand, Lanius, et al., 2012), perhaps because childhood
sexual abuse and dissociation are associated with poor
social cognition (Nazarov et al., 2014). Marked internal
conflict among self states is an indicator of poorer prog-
nosis in this population (Kluft, 1994). Significant reduc-
tion in these difficulties indicates that these patients are
progressing in treatment, gaining stability, and making
interpersonal and intrapersonal improvements.
Clinicians must be mindful of attachment difficulties
common among DD patients and be attentive to ways
in which these difficulties manifest. DD experts strongly
recommend focusing on attachment as it pertains to the
therapeutic alliance as well as the development of
healthy relationships, throughout all stages of treatment
(Brand et al., 2012). Few patients were highly stressed
bymistrust or conflict with the treatment team, which is
notable, given the childhood maltreatment and attach-
ment difficulties endemic among this group (Foote
et al., 2006; Johnson et al., 2006; Sar et al., 2007). This
may suggest that clinicians and patients were generally
successful in noticing andmanaging patients’ traumatic
transference and attachment difficulties (Loewenstein,
1993; Kluft, 1990).
3.1. Limitations
There are notable limitations to the study, primarily
centring on the small sample, which may be a particu-
larly motivated sample of patients or a skilled sample of
clinicians. There was a high attrition throughout the
TOP DD study, and the current study did not obtain
patient-reported data. Due to small sample size, some
variables were dichotomized, preventing more detailed
analyses of nuanced treatment concerns, such as how
self-harm is linked to IPV. Finally, we did not examine
patients’ time in treatment prior to the TOP DD study
or alliance, thus some of our inferences are limited.
3.2. Future research and conclusion
Future longitudinal research should obtain self-report
data from DD patients, as well as clinicians, and seek to
find methods for improving retention in DD treatment
outcome studies. This study demonstrates that DD
patients continue to show a range of improvements
during six years of dissociation-focused, phasic treat-
ment. Therapists’ reports indicated significant improve-
ments in patients’ global functioning; reductions in
stress related to family relationships and internal con-
flict among self-states; and decreased sexual revictimi-
zation. Additionally, patients required significantly
fewer hospitalizations. Despite improvements, patients
continued to experience difficulties in their romantic
relationships, friendships, and occupational function-
ing. Findings provide support for the staged model of
complex trauma treatment. However, it is clear that
treatment of severe DD patients must address their
profoundly damaged capacity for relationships (Freyd,
1996; Herman, 1992; Putnam, Harris, Lieberman,
Putnam, & Amaya-Jackson, 2015). Research needs to
continue studying trauma-focused DD treatments and
their economic and psychosocial impact.
Highlights
● Until recently, there has been a paucity of long-
itudinal treatment research on dissociative disor-
der (DD) patients.
● Sixty-one therapists who participated in the
initial phase of the Treatment of Patients with
Dissociative Disorders (TOP DD) study
answered questionnaires about their study
patient’s stressors, quality of life, global func-
tioning, victimization, and safety.
● Longitudinal analyses demonstrated patients had
significantly fewer stressors, instances of sexual
revictimization, and psychiatric hospitalizations.
● Longitudinal analyses demonstrated that patients
were functioning at a higher level overall.
● Despite marked initial difficulties and functional
impairment, DD patients benefit from specialized
treatment.
Note
1. We use the term ‘self-state’ to refer to dissociated states
which are also referred to as identities, parts, personal-
ities, and alters.
Disclosure statement
No potential conflict of interest was reported by the authors.
References
Ali, W., & Smartt, P. (2009). Therapeutic models for mental
injury as a result of sexual abuse: Overview of the evidence
from selected literature. HSAC Report, 2009, 9–23.
American Psychiatric Association. (2000). Diagnostic and
statistical manual of mental disorders DSM-IV-TR (text
revision) (4th ed.). Washington, DC: Author.
6 A. C. MYRICK ET AL.
Brand, B. L., Classen, C. C., McNary, S. W., & Zaveri, P.
(2009). A review of dissociative disorders treatment stu-
dies. The Journal of Nervous and Mental Disease, 197,
646–654. doi:10.1097/NMD.0b013e3181b3afaa
Brand, B. L., Lanius, R., Vermetten, E., Loewenstein, R. J.,
& Spiegel, D. (2012). Where are we going? An update on
assessment, treatment, and neurobiological research in
dissociative disorders as we move toward the DSM-5.
Journal of Trauma & Dissociation, 13(1), 9–31.
doi:10.1080/15299732.2011.620687
Brand, B. L., Loewenstein, R. J., & Spiegel, D. (2014).
Dispelling myths about dissociative identity disorder
treatment: An empirically based approach. Psychiatry:
Interpersonal and Biological Processes, 77(2), 169–189.
doi:10.1521/psyc.2014.77.2.169
Brand, B. L., McNary, S. W., Myrick, A. C., Classen, C.,
Lanius, R., Loewenstein, R. J., . . . Putnam, F. W. (2013).
A longitudinal naturalistic study of patients with disso-
ciative disorders treated by community clinicians.
Psychological Trauma: Theory, Research, Practice, and
Policy, 5(4), 301–308. doi:10.1037/a0027654
Brand, B. L., Myrick, A. C., Loewenstein, R. J., Classen, C.
C., Lanius, R., McNary, S. W., . . . Putnam, F. W. (2012).
A survey of practices and recommended treatment inter-
ventions among expert therapists treating patients with
dissociative identity disorder and dissociative disorder
not otherwise specified. Psychological Trauma: Theory,
Research, Practice, and Policy, 4(5), 490–500.
doi:10.1037/a0026487
Coons, P. M., & Bowman, E. S. (2001). Ten-year follow-up
study of patients with dissociative identity disorder.
Journal of Trauma & Dissociation, 2, 73–89.
doi:10.1300/J229v02n01_09
Coons, P. M., & Millstein, V. (1986). Psychosexual distur-
bances in multiple personality: Characteristics, etiology,
and treatment. Journal of Clinical Psychiatry, 47, 106–110.
Ellason, J. W., & Ross, C. A. (1997). Two-year follow-up of
inpatients with dissociative identity disorder. The
American Journal of Psychiatry, 154(6), 832–839.
doi:10.1176/ajp.154.6.832
Ferry, F. R., Brady, S. E., Bunting, B. P., Murphy, S. D.,
Bolton, D., & O’Neill, S. M. (2015). The economic bur-
den of PTSD in Northern Ireland. Journal of Traumatic
Stress, 28(3), 191–197. doi:10.1002/jts.22008
Foote, B., Smolin, Y., Kaplan, M., Legatt, M. E., & Lipschitz,
D. (2006). Prevalence of dissociative disorders in psychia-
tric outpatients. American Journal of Psychiatry, 163(4),
623–629. doi:10.1176/ajp.2006.163.4.623
Freyd, J. J. (1996). Betrayal trauma: The logical of forgetting
childhood abuse. Cambridge,MA: Harvard University Press.
Herman, J. L. (1992). Trauma and recovery. New York, NY:
Basic Books.
International Society for the Study of Trauma and
Dissociation [ISSTD]. (2011). Guidelines for treating
dissociative identity disorder in adults, third revision.
Journal of Trauma & Dissociation, 12(2), 115–187.
doi:10.1080/15299732.2011.537247
Jepsen, E. K. K., Bad, M., Langeland, W., Sexton, H., &
Heir, T. (2014). Inpatient treatment for early sexually
abused adults: A naturalistic 12-month follow-up study.
Psychological Trauma: Theory, Research, Practice, &
Policy, 6, 142–151. doi:10.1037/a0031646
Jepsen, E. K. K., Svagaard, T., Thelle, M. I., McCullough, L.,
& Martinsen, E. W. (2009). Inpatient treatment for adult
survivors of childhood sexual abuse: A preliminary out-
come study. Journal of Trauma & Dissociation, 10, 315–
333. doi:10.1080/15299730902956812
Johnson, J. G., Cohen, P., Kasen, S., & Brook, J. S. (2006).
Dissociative disorders among adults in the community,
impaired functioning, and axis I and II comorbidity.
Journal of Psychiatric Research, 40, 131–140. doi:10.1016/
j.jpsychires.2005.03.003
Kluft, R. P. (1984/1985). The treatment of multiple person-
ality disorder (MPD): Current concepts. Directions in
Psychiatry, 5(24), 1–9.
Kluft, R. P. (1990). Preliminary notes on MPD and allied
forms of dissociative disorder not otherwise specified in
practicing psychotherapists. Dissociation: Progress in the
Dissociative Disorders, 3(2), 113–122.
Kluft, R. P. (1994). Treatment trajectories in multiple per-
sonality disorder. Dissociation, 7, 63–76.
Lampe, A., Hofmann, P., Gast, U., Reddemann, L., &
Schüßler, G. (2014). Long-term course in female survi-
vors of childhood abuse after psychodynamically
oriented, trauma-specific inpatient treatment: A natura-
listic two-year follow-up. Zeitschrift fur Psychosomatische
Medizin und Psychotherapie, 60(3), 267–282.
Loewenstein, R. (1993). Posttraumatic and dissociative
aspects of transference and countertransference in the
treatment of multiple personality disorder. In R. P. Kluft
& C. G. Fine (Eds.), Clinical perspectives on multiple
personality disorder (pp. 51–85). Washington, DC:
American Psychiatric Association.
Myrick, A. C., Webermann, A. R., Putnam, F. W., & Brand, B.
L. (in press). Treatment of dissociative disorders and reported
changes in inpatient and outpatient cost estimates.
Nazarov, A., Frewen, P., Parlar, M., Oremus, C.,
MacQueen, G., McKinnon, M., & Lanius, R. (2014).
Theory of mind performance in women with posttrau-
matic stress disorder related to childhood abuse. Acta
Psychiatrica Scandinavica, 129(3), 193–201. doi:10.1111/
acps.2014.129.issue-3
Putnam, F. W. (1997). Dissociation in children and adoles-
cents: A developmental perspective. New York, NY:
Guilford Press.
Putnam, F. W., Harris, W., Lieberman, A., Putnam, K., &
Amaya-Jackson, L. (2015). Childhood adversity narra-
tives. Retrieved from http://www.canarratives.org
Rosenkranz, S. E., & Muller, R. T. (2011). Outcome follow-
ing inpatient trauma treatment: Differential response
based on pre-treatment symptom severity. Psychological
Trauma: Theory, Research, Practice, & Policy, 3, 453–
461. doi:10.1037/a0021778
Sachsse, U., Vogel, C., & Leichsenring, F. (2006). Results of
psychodynamically oriented trauma-focused inpatient
treatment for women with complex posttraumatic stress
disorder (PTSD) and borderline personality disorder
(BPD). Bulletin of the Menninger Clinic, 70, 125–144.
doi:10.1521/bumc.2006.70.2.125
Sar, V., AkyüZ, G., & Doğan, O. (2007). Prevalence of
dissociative disorders among women in the general
population. Psychiatry Research, 149, 169–176.
doi:10.1016/j.psychres.2006.01.005
Steil, R., Dyer, A., Priebe, K., Kleindienst, N., & Bohus, M. J.
(2011). Dialectical behavior therapy for posttraumatic stress
disorder related to childhood sexual abuse: A pilot study of
an intensive residential treatment program. Journal of
Traumatic Stress, 24, 102–106. doi:10.1002/jts.20617
Webermann, A. R., Brown, D. J., Brand, B. L., Loewenstein,
R. J., & Putnam, F. W. (2013, November). An explora-
tion of the costs of treatment over time among the TOP
DD patients. Paper presented at the 30th Annual
International Society for the Study of Trauma and
Dissociation (ISSTD) Conference, Baltimore, MD.
EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY 7
